StockNews.com Begins Coverage on Mannatech (NASDAQ:MTEX)

Equities research analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued on Monday. The brokerage set a “buy” rating on the stock.

Mannatech Price Performance

NASDAQ:MTEX opened at $11.63 on Monday. Mannatech has a 52-week low of $6.75 and a 52-week high of $16.49. The stock has a fifty day moving average of $12.21 and a 200 day moving average of $9.87. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.74 and a current ratio of 1.25. The firm has a market capitalization of $21.92 million, a price-to-earnings ratio of -14.36 and a beta of 1.06.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.